Robert Hawkins

Directeur/Membre du Conseil chez BIVICTRIX THERAPEUTICS PLC

Fortune : 32 945 $ au 31/05/2024

69 ans

Health Technology

Consumer Services

Postes actifs de Robert Hawkins

Sociétés	Poste	Début	Fin
BIVICTRIX THERAPEUTICS PLC	Directeur/Membre du Conseil	22/09/2021	-
BIVICTRIX THERAPEUTICS PLC	Independent Dir/Board Member	22/09/2021	-

Sociétés	Poste	Début	Fin
INSTIL BIO, INC.	Directeur Technique/Scientifique/R&D	11/11/2022	01/05/2024
INSTIL BIO, INC.	Directeur/Membre du Conseil	01/02/2019	01/07/2020
Instil Bio (UK) Ltd.	Directeur Général	-	01/01/2020
Instil Bio (UK) Ltd.	Fondateur	-	01/01/2020
The University of Manchester	Corporate Officer/Principal	-	-
MOTIF BIO PLC	Directeur/Membre du Conseil	14/06/2021	-

University of Cambridge	Doctorate Degree
University College London	Doctorate Degree

Internationale

Royaume-Uni	7
Etats-Unis	2

Opérationnelle

Director/Board Member	3
Doctorate Degree	2
Independent Dir/Board Member	1

Sectorielle

Health Technology	4
Consumer Services	4

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	2
BIVICTRIX THERAPEUTICS PLC	Health Technology
INSTIL BIO, INC.	Health Technology

Entreprise privées	2
Motif Bio Plc Motif Bio Plc Pharmaceuticals: MajorHealth Technology Motif Bio Plc is a clinical stage biopharmaceutical company, which engages in the development and commercialization of pharmaceutical formulations. The company focuses on developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. It offers Iclaprim, a novel diaminopyrimidine antibiotic that inhibits an essential bacterial enzyme called dihydrofolate reductase. The company was founded by Jonathan E. Gold on November 20, 2014 and is headquartered in Princeton, NJ.	Health Technology
Instil Bio (UK) Ltd.

Entreprise privées

Health Technology

Instil Bio (UK) Ltd.